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We  have  shown  previously  that detection  of circulating  antibodies  against  mimotopes  selected  by phage
display  were  useful  in neurocysticercosis  diagnosis.  However,  circulating  antigens  may  also  be  useful  in
patients’ clinical  follow-up.  Therefore,  we aimed  to select  novel  combinatorial  antibodies,  single-chain
variable  fragment  (scFv),  which  can  be used  for speciﬁc  antigens  with  pre-deﬁned  afﬁnity  and  speciﬁcity
without  prior  immunization.  A phage  scFv  antibody  library  was  selected  against  Taenia  solium  mimotopes
displayed  on  phages  coupled  in  beads  and  total  saline  extract  of  T.  solium  metacestodes  (S)  immobilized  on
microtiter  plate  wells.  After  two  rounds  of selection,  96 phage  clones  were  evolved  and  validated  against
each  target  by  enzyme  linked  immunosorbent  assay  (ELISA),  and  dot-blot,  and  three  speciﬁc  antibodies
(B6,  G10  and  A4)  were  further  characterized  by sequencing  and  indirect  immunoﬂuorescence  (IFI)  assays.
IFI revealed  tegument  staining  for the  B6,  while  the  others  showed  a non-uniform  staining  in  the  whole
parasite.  The  selected  scFvs  were  used  to capture  their  antigen  targets  that  were  elucidated  through  mass
spectrometry,  and  used  for antibody  detection  in  NC  patients’  sera by  ELISA,  which  achieved  sensitivities
greater  than  97%  and  speciﬁcities  above  95%.  We  have  successfully  developed  scFv  antibodies  against
important  mimotopes  used  in  NC  diagnosis,  and  can  be  further  explored  to  detect  circulating  antigens
for  clinical  follow-up  of  patients  with  NC. Our  strategy  also highlighted  the  possibility  of using  this
combinatorial  approach  to  select,  capture  and  characterize  speciﬁc  antigens  to  better  understand  this
ion  anintriguing  parasite  infect
. Introduction
Taenia solium taeniasis and cysticercosis are endemic parasitic
nfections in several African, Asian and South American countries
1]. Human neurocysticercosis (NC) is an important but neglected
ause of epilepsy in developing countries where the parasite occurs
2].
The selection of antibodies from combinatorial libraries dis-
layed on the surface of ﬁlamentous phage has become important
or the generation of reagent, diagnostic, and therapeutic molecules
nd for the study of the natural immune response [3–5].Recently, phage display has been shown to be a cost-effective
echnique for the production of antibody fragments such as a bind-
ng fragment (Fab) or a single-chain variable fragment (scFv) [6–8].
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The variable fragment (Fv) of the immunoglobulin molecule is the
region with antigen-binding function. A scFv combinatorial anti-
body consists of heavy (VH) and light (VL) chains of the variable
region, which are joined by a ﬂexible peptide linker, and can be
functionally expressed in Escherichia coli to improve afﬁnity and
speciﬁcity without prior immunization [9].
ScFvs have many advantages and can mimic  the maturation pro-
cess of human antibody, so that it is possible to obtain a high afﬁnity
antibody from this selection. If an antibody library of human origin
is used, the selected antibody is most suitable to human administra-
tion and is potentially applicable to clinical diagnosis and treatment
of infectious diseases [10].
In this study we  used a phage display technology to enable
the direct isolation of scFv antibodies against (I) bead coupled
mimotopes displayed in phages and (II) metacestode antigens
by using solid-phase bound T. solium extract to screen out the
phage display antibody that recognizes these antigens and proceed-
ing immunoﬂuorescence, and mass spectrometry to characterize
antigens captured by each scFv clone selected. Potential of these
antigens was evaluated to diagnose neurocysticercosis in serum
samples.
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. Materials and methods
.1. Ethics statement
This study was conducted according to the ethical guidelines of
he Brazilian Health Ministry after being approved by the Research
thics Committee of Universidade Federal de Uberlândia (UFU),
tate of Minas Gerais, Brazil.
.2. Antigens
T. solium metacestodes were collected from massively infected
ig muscle and were carefully dissected from the host tissues,
ashed repeatedly using saline solution and stored at −20 ◦C. Total
aline extract of T. solium metacestodes (S) was prepared as previ-
usly described [11].
Phage clones displaying speciﬁc peptides to NC were obtained
ccording to Ribeiro [12].
.3. scFv phage-display library
Antibodies against different peptides displayed in phages and
otal saline extract of T. solium were selected using a scFv phage
isplay library constructed at the Laboratory of Nanobiotecnology
UFU) based on a pool of patients’ peripheral blood mononuclear
ells (PBMCs) with multiple diseases, with a library size of 2.3 × 106.
escue of the library was performed as recommended [13].
.4. Library screening
For selection three rounds of biopanning were performed using
wo peptides displayed in phages, previously described [12] or total
aline extract of T. solium metacestodes, named herein as (a), (b) and
c) procedures.
Bead coupled phages NC22 and NC41 were used (1010 plaque
orming unit (PFU)). Wild type M13  phage was used in a previ-
us subtractive step of panning. Coupling of each phage to beads
Dynabeads® M-270 Epoxy, Invitrogen Life Sciences, USA) fol-
owed bead manufacturer’s recommendations. To screen library
nd select scFv clones, bead coupled with wild type phage (20 l)
ere put in a microtube and incubated with scFv library (50 l)
or 1 h, during this period those scFv clones that interacted with
ild type phage were excluded. Next, supernatant was collected
sing a magnetic apparatus and transferred to a new tube contain-
ng beads coupled with the target mimotope displayed on phage
(a) NC22 or (b) NC41), and incubated for 1 h at 37 ◦C. Supernatant
as discarded and speciﬁc scFv clones were eluted using 100 mM
lycine–HCl, pH 2.2 for 10 min  at room temperature (RT), neutral-
zed with Tris base (2 M,  pH 9.1) and then transferred to a XL1 Blue
ulture for ampliﬁcation and titration [13].
To select scFv antibodies against total saline extract of T. solium
etacestodes (c) microplates (MaxisorpTM, Thermo Scientiﬁc, USA)
ere coated overnight with 1 g/well of target antigen at 4 ◦C in
arbonate buffer (0.1 M,  pH 9.6), blocked with bovine serum albu-
in  (BSA 3% in Tris-buffered saline (TBS), 37 ◦C, 1 h) and washed
ix times (TBS containing Tween®-20 (T) 0.1%). Phage scFv library
109 PFU) was added and incubated (1 h, RT) under gentle agitation.
lates were washed ten times with TBS-T 0.1%. Bound phages were
luted, ampliﬁed and titrated as follows.
For ampliﬁcation the culture was grown until optical density
OD) at 600 nm reached 1.0 and after was infected with VCS-M13
elper phage (1012 PFU, Stratagene, USA). Ampliﬁed phages were
ubmitted to another round of panning. Input and output phages
ere titrated on Luria Bertani (LB)/carbenicillin plates. Preliminary Letters 156 (2013) 59– 67
data showed that two selection rounds resulted in a high recovery
of antigen-binding phage.
2.5. Production of soluble single-chain antibodies
Antibody fragments were produced by electroporating
phagemid DNA (20 ng) into E. coli (One Shot® TOP10 ElectrocompTM
E. coli, Invitrogen, USA), and plating the transformed cells on
LB/carbenicillin plates. The bacterial culture was  incubated under
rotation (37 ◦C, 250 rpm) in Super broth (SB) agar/carbenicillin
containing glucose 2% (5 h, OD600 = 1.0), induced by adding
isopropyl--d-thiogalactopyranoside (IPTG, 2 mM,  Sigma, USA),
and further incubated overnight (30 ◦C, 250 rpm). Supernatant
containing antibody was harvested after centrifugation (5000 × g,
4 ◦C, 15 min), further clariﬁed through a 0.45 mm ﬁlter (Millipore,
USA) and His-tagged scFv fragments were puriﬁed by immobilized-
metal (Ni) afﬁnity chromatography (HisTrapTM HP, GE Healthcare,
USA). ScFv clones had histidine (His) and hemagglutinin (HA)
tags and puriﬁed fractions were concentrated and checked for the
presence of antibody fragments by immunoblotting. Each selected
scFv clone was  subjected to sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) 16%, transferred to a nitrocellulose
membrane, blocked with (w/v) skimmed milk 5% in PBS and then
sequentially probed with anti-HA peroxidase conjugated (1:1000)
(Roche, Switzerland) overnight 4 ◦C. All washes were done in
PBS-T 0.05%. Following appropriate color development using the
3,3′-diaminobenzidine (DAB) substrate system (Sigma, USA), the
membrane was washed extensively in distilled water, dried, and
imaged on a ﬂatbed scanner. To verify the integrity of each selected
scFv clone, puriﬁed antibodies were analyzed on SDS PAGE 16% gel
under non reducing conditions, gel was  stained with silver nitrate
[14].
2.6. Selection of phage antibodies
2.6.1. Phage ELISA
We  used phage ELISA to verify expression of the scFvs. Brieﬂy,
supernatants containing soluble selected scFvs antibodies were
incubated in ELISA microplates. After overnight incubation at 4 ◦C
plates were blocked with PBS-BSA 3% (1 h, 37 ◦C) followed by two
washes with PBS and three washes with PBS-T 0.05%. After, plates
were incubated with anti-HA horseradish peroxidase conjugate
(1:2000 in PBS-BSA 3%, Roche, Switzerland). Plates were washed
again as described earlier. Orthophenylenediamine (OPD), peroxi-
dase substrate was  added, and the absorbance was read at 492 nm,
using an ELISA reader (TP Reader, China).
Those clones positive for scFv expression were tested to verify
antigen recognition, immuno 96 Micro-WellTM plates (Sigma, USA)
were coated with each antigen: (a) NC22 (1010 PFU/well), (b) NC41
(1010 PFU/well) and (c) total saline extract (1 g/well) and tested
by ELISA for binding to each target as described above, using scFvs
at a 1:250 dilution in blocking solution (PBS-BSA 3%).
2.7. Characterization of single-chain antibodies
2.7.1. Dot blot
Speciﬁcity tests were done by dot blot. Brieﬂy, 1010 PFU of each
target phage: NC22, NC41 and its negative control (wild type M13)
and 1 g from total saline extract using an on related antigen as
negative control were blotted on nitrocellulose membranes. After,
membranes were blocked by using PBS-BSA 3%, washed with TBS-T
0.05% and selected scFv antibodies were added at 1:150 in blocking
solution and incubated for 1 h at room temperature, then anti-HA
peroxidase conjugated 1:1000 in blocking solution was added and
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ncubated for 1.5 h, after three washings, reaction was developed
y adding DAB (Sigma, USA).
.7.2. ELISA
To conﬁrm reactivity and speciﬁcity from those scFv clones
ositive in ELISA, plates were coated with each antigen: (a)
C22 (1010 PFU/well), (b) NC41 (1010 PFU/well) and (c) total saline
xtract (1 g/well). As negative control wild type M13  phage
1010 PFU/well) was used for procedures (a) and (b), and a non-
elated antigen for procedure (c). ELISA was performed as described
bove.
.7.3. DNA sequencing
Clones from the second round of panning were randomly picked
rom the output plates of the last selection round. Each colony
as grown in SB/carbenicillin broth, and cultures were incubated
vernight at 37 ◦C, 250 rpm. Plasmids were extracted from the
acterial pellets using the Miniprep kit (Qiagen, USA), analyzed
n agarose 0.8% gels and sequenced using an automatic capillary
equencer, MegaBACE 1000 Genetic Analyzer (Amersham Bio-
ciences, USA) with −96gIII and primer (5′-CCC TCA TAG TTA GCG
AA CG-3′), corresponding to the vector sequence downstream of
he scFv gene. After, the amino acid sequences were translated and
nalyzed by using IgBLAST (http://www.ncbi.nlm.nih.gov/igblast/).
.7.4. Immunoﬂuorescence (IF)
Prior to staining, metacestodes were included in tissue freezing
edium (Sakura, Netherlands) and frozen at −70 ◦C. Thick sec-
ions were obtained (2 m),  placed on glass slides and air dried
or 30 min. The scFv preparations (10 g) were diluted in PBS and
ncubated for 40 min  at 37 ◦C. After 2 washes with PBS, sections
ere incubated for 40 min  at 37 ◦C with ﬂuorescein isothiocyanate
FITC) labeled anti-HA (6 g/ml) and counterstained with Evans
lue. After two PBS washes, slides were mounted using buffered
lycerin and cover slides. Negative controls were made using a
on related scFv. Binding was detected by ﬂuorescence microscopy
LSM 510 Meta, Carl Zeiss, Germany).
.8. Afﬁnity puriﬁcation of the corresponding native antigen
To characterize the corresponding native antigens for each scFv
btained, selected clones were coupled to Ni sepharose resin.
rieﬂy, resin (Ni Sepharose 6 Fast Flow – GE Healthcare Life
ciences) was prepared according to the manufacturer’s recom-
endation, with modiﬁcations. A pre-wash with 5 resin volumes
f distilled water and two with washing/binding buffer (20 mM
a2HPO4, 0.15 M NaCl, pH 7.0) was made. After, clones (135 g
ach) were added (each clone on a separate tube) and incubated
nder gentle shaking for 1 h at room temperature. After two wash-
ngs using washing/binding buffer, total saline extract was added
540 g), incubated and then resin was washed as described.
o elute native antigens captured a buffer containing imidazole
20 mM sodium phosphate, 0.5 M NaCl, 500 mM imidazole, pH 7.4)
as used, and after a 5 min  incubation supernatant was collected.
Eluted fractions were analyzed for protein content according to
radford [15]. Proteins were visualized in SDS-PAGE 16% by silver
taining [14]. Gel analysis was performed using a graphical method
o generate protein lane proﬁle plot of each antigenic fraction, by
mage J version 1.44 software (National Institutes of Health, EUA);
nd then peaks referred to bands were compared with protein stan-
ard marker (Real Biotech, RECOMTM Blue Wide Range Prestain
arker, Taiwan) to estimate their relative molecular weight. Letters 156 (2013) 59– 67 61
2.9. Determination of native antigens
Eluted proteins were precipitated out of solution using the
ProteoExtract® kit (Calbiochem, Germany) and the protein pellet
was left to dry overnight in a sterile fume hood. The pellet was  then
resuspended in ammonium bicarbonate (50 mM,  pH 8.0) and sub-
jected to an in-solution tryptic digestion (Mike Myers, Cold Spring
Harbor modiﬁed by Brett S. Phinney, UC Davis Proteomics Core).
Digested peptides were then de-salted using aspire tips (RP30 Tips,
Thermo-Fisher Scientiﬁc, USA) before being resuspended in the
loading buffer.
2.9.1. LC–MS/MS methods
Digested peptides were analyzed using a LTQ-FT (Thermo-
Fisher Scientiﬁc, USA) coupled with a MG4  paradigm HPLC
(Michrom, USA). The samples were loaded onto a Michrom cap
trap (0.5 mm × 2 mm). The peptides were then separated using a
Michrom Magic C18AQ (200 m × 150 mm)  reversed-phase col-
umn  and eluted using a gradient with a duration of 60 min. Collision
induced dissociation was applied to the peptide samples and data
was acquired with an isolation width of 1, a normalized collision
energy of 35 and a resolution of 50,000. The spray voltage on the
Michrom captive spray was set to 1.8 kV with a heated transfer
capillary temperature of 200 ◦C.
2.9.2. Data analysis
Raw data was analyzed using X!Tandem and visualized using
Scaffold (Proteome Software, version 3.01). Samples were searched
on Uniprot T. solium (304 protein sequences) databases appended
with the cRAP (commonly found laboratory contaminants) and the
reverse decoy databases.
2.10. ELISA to detect IgG using antigens captured by scFv clones
To verify the diagnostic potential of captured antigens related
to each scFv clone obtained, ELISA tests were made.
2.10.1. Serum samples
Serum samples were collected from 90 subjects attended at the
Laboratory of Clinical Analysis at the Clinical Hospital (Groups 1
and 2) and from the Laboratory of Parasitology (Group 3) of the
Universidade Federal de Uberlândia in the State of Minas Gerais,
Brazil. Group 1 (G1) consisted of 30 patients with deﬁnitive diag-
nosis of NC, as follows: (a) all patients presented at least one
type of clinical manifestation suggestive of NCC such as: epilepsy,
cephalea, dizziness, dementia, faintness, hydrocephalus, and no
signs or symptoms of cysticercosis in other organs; (b) all patients
came from or lived in an area where cysticercosis is endemic; (c)
for immunodiagnosis, serum samples were positive in an ELISA
test for the detection of IgG anti-metacestodes of T. solium; (d)
they presented evidence of parasite in neuroimaging. Group 2 (G2)
consisted of 30 patients who harbored other parasites: Ascaris lum-
bricoides (n = 4), Enterobius vermicularis (n = 4), hookworm (n = 5);
Hymenolepis nana (n = 3), Schistosoma mansoni (n = 3), Strongyloides
stercoralis (n = 4), Taenia sp. (n = 4) and Trichuris trichiura (n = 3).
Group 3 (G3) consisted of 30 healthy volunteers based on their
clinical proﬁle. Although they came from an area where cysticer-
cosis is endemic, all volunteers from this group did not present
evidence of household contact with T. solium infection or a history
of taeniasis or cysticercosis. In addition, these individuals had three
fecal samples that tested negatively by the parasitological methods
[16,17].
62 V.d.S. Ribeiro et al. / Immunology Letters 156 (2013) 59– 67
F  nm fo
( nce. O
a
2
o
(
i
w
e
a
t
s
3
j
a
T
a
Oig. 1. Binding speciﬁcity of scFv from pannings a, b and c. ELISA absorbance at 492
A),  NC41 (B) and total saline extract of T. solium metacestodes (C) by ELISA absorba
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.10.2. Antibody detection by ELISA
Preliminary experiments were carried out to determine the
ptimal conditions for ELISA, through block titration of reagents
antigens, sera and conjugate).
ELISA was carried out as previously described [18] with mod-
ﬁcations. Polystyrene microplates (Interlab, Brazil) were coated
ith each antigen (total saline extract and antigens captured by
ach scFv clone) 5 g/ml in carbonate bicarbonate buffer, pH 9.6
nd incubated overnight at 4 ◦C. Microplates were washed three
imes with PBS containing 0.05% Tween 20 (PBS-T). Then serum
amples were diluted 1:200 in PBS-T and incubated for 60 min  at
7 ◦C. After another step of washing, the immunoenzymatic con-
ugate (peroxidase-goat anti-human IgG, Fc speciﬁc; Sigma) was
dded diluted 1:2000 in PBS-T and incubated for 60 min  at 37 ◦C.
he assay was developed after an additional washing procedure by
dding the enzyme substrate consisting of hydrogen peroxide and
PD in 0.1 M citrate phosphate Na2HPO4 buffer pH 5.5 for 15 min.r selected phage clones. Dashed bar shows scFv reactivity against the targets NC22
pen bar shows negative controls: wild type M13  phage (A and B) and non-related
The reaction was interrupted by the addition of 25 l per well of
2 N H2SO4. Optical densities (OD) were determined at 492 nm in an
ELISA reader (Titertek Plus, Flow Laboratories, USA).
2.11. Statistical analyses of ELISA data
Analyses were performed using GraphPad software package
5.0 (GraphPad Software Inc., San Diego, USA). Optimum point for
each condition of ELISA reaction and cut-off points were estab-
lished using a two-graph receiver operating characteristic curve
(TG-ROC) [19] based on ELISA results from patients positive for neu-
rocysticercosis (positive controls) and individuals from the other
two groups (other parasites and healthy). ELISA reactivity index
(RI) was  obtained by the ratio between OD and cut-off. Values of
RI greater than the optimum point of reaction for each extract
were considered positive (RI > 1). Sensitivity (Se) and speciﬁcity
(Sp) were calculated accordingly to the formulas: Se = a/(a + b) and
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p = d/(c + d) where a = is true positive, b = false positive, c = false
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Receiver operating characteristic curves (ROC) were built to
escribe the tests [21]. The area under ROC curve (AUC), an over-
ll index of diagnostic accuracy, was calculated, values close to
 indicate an informative test; and close to 0.5 indicate an unin-
ormative test [22]. Likelihood ratio (LR), an efﬁciency diagnostic
arameter independent of prevalence [19] were calculated, as fol-
ows: LR+ = Se/(1 − Sp), which indicates how likely patients with
eurocysticercosis are to have a positive test result compared with
ther patients. Probability (P) values of <0.05 were regarded as sig-
iﬁcant and 95% conﬁdence intervals (CI) were provided to Se, Sp
nd AUC statistical calculations.
. Results
.1. Analysis of eluted phage displaying scFv antibodies
The phage output increased at the second round indicating that
inder clones were isolated and ampliﬁed successfully. The obser-
ation of speciﬁc binders ampliﬁcation was also evident from the
hage ELISA whereby as the stringency of the selection conditions
ncreased, more phage displaying scFvs with better binding capa-
ilities were successfully isolated.HisTrapTM HP column eluted fractions of scFvs were subjected
o SDS-PAGE and Western blot to identify the purity and molecular
ass, the puriﬁed antibodies showed only one protein band with
he expected size of approximately 29 kDa. Puriﬁed scFv showedubated with 10 g of soluble scFv for 40 min. After washing, bound scFv was  labeled
l, (B) B6, (C) G10 and (D) A4.
the expected band, without minor small molecular weight bands
detected, indicating no degradation of the scFv during puriﬁcation.
3.2. Characterization of antibody binding speciﬁcity
The binding of clones expressing scFv was measured by using
ELISA microtiter plates (we  analyzed 21 clones from pannings a
and b, and 10 from panning c). Positive binding was  deﬁned as
an absorbance for immobilized antigen that was two-fold above
negative controls (Fig. 1).
The antibodies obtained against NC22 (B6 and E4) and NC41
(H12 and G10) that were neither reactive against M13 wild type
phage, and those against total saline extract (A1 and A4) with-
out reactivity for negative control were expressed in large scale,
puriﬁed and re-tested for speciﬁcity. After speciﬁcity tests using
puriﬁed scFvs, clones B6, G10 and A4 were selected for further
analyses.
In dot blot all selected scFvs showed to be speciﬁc for its
targets. Each antibody showed a different amino acid sequence
of immunoglobulin variable domains. Sequence analysis of the
selected scFv clones revealed three unique sequences.
3.3. Immunoﬂuorescence localization of the antigens recognized
by the representative scFvsTo conﬁrm reactivity and determine the recognition patterns,
soluble scFvs were separately incubated with T. solium metaces-
tode and the bound scFv was  visualized by indirect ﬂuorescence. No
ﬂuorescence was  obtained with the negative controls. The patchy
64 V.d.S. Ribeiro et al. / Immunology Letters 156 (2013) 59– 67
Fig. 3. Electrophoretical proﬁles of total extract and native antigens. Total saline extract of T. solium (S) and obtained fractions from afﬁnity puriﬁcation of the corresponding
native antigens for each scFv clone (A4, B6 and G10) and Image J software analysis, in 16% SDS-PAGE, silver stained are shown. MW,  molecular weight standard in kilodaltons
(kDA).
Table 1
Native antigens revealed through mass spectrometry.
Clone Accession number Description Gene MW (kDa)
A4 G3GE64 Ts18 variant 2 Ts18v2 9455.10
B6  P68555 Actin ACT1 41,727.50
pyruv
M
s
d
r
c
s
3
b
o
s
1
F
eG10  D2U5C3 Phosphoenol
W,  molecular weight in kilodaltons.
taining observed to A4 and G10 clones was not uniform, but rather
istributed in small, interspersed textural patches with no apparent
egularity. ScFvs produced intermittent patches of bright ﬂuores-
ence, clearly distinct (Fig. 2). Only B6 showed a belted pattern of
taining at the tegument.
.4. Determination of native antigen for each scFv clone
The analysis of electrophoretical proﬁles of antigens captured
y each clone showed similar proﬁles. Polypeptide deﬁned bands
r intervals ranging from 10 to >140 kDa were detected on the total
aline extract (Fig. 3). Clones speciﬁcally recognized antigens from
0–15, 17.5, 18, 20, 27, 29, 31, 35, 37–42, 45, 50, 53, 66, 78, 127 and
ig. 4. IgG detection in serum samples. Samples from patients with NC (n = 30), other para
xtract of T. solium metacestodes and the native antigens correspondent to each scFv clonate carboxykinase pepck 54,088.40
140. Although minor differences in band peaks can be observed,
mass spectrometry revealed different proteins captured for each
scFv clone (Table 1). The corresponding native antigen represents
the most abundant protein revealed by LC–MS/MS procedure.
3.5. IgG detection
Analyzing Fig. 4 we  can observe in G1 positivity rates of 80%
(24/30) for total saline extract of T. solium (S). Considering captured
antigens 100% (30/30) of samples were positive for the antigen cap-
tured by A4 and 97% (29/30) for antigens captured using B6 and G10
clones. In G2, 26.6% (8/30) were positive when using S and for cap-
tured antigens 3.3% (1/30) for A4 antigen, 6.6% (2/30) for B6, there
sites (n = 30) and healthy individuals (n = 30) were tested using each antigen: saline
e G10, A4 and B6.
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as no cross reactivity when testing antigens captured by G10. In
3, positivity was 6.6% (2/30) for S and G10 target and 3.3% (1/30)
or A4 and B6 targets.
Cross reactivity in G2 when using S was due to samples from
atients harboring: A. lumbricoides (4/8), hookworm (2/8), S. ster-
oralis (1/8), H. nana (1/8) and S. mansoni (1/8). No samples were
ositive when using antigens captured by G10. For antigens cap-
ured by A4, reactivity was due to E. vermicularis (1/1), considering
6 target cross reactivity occurred with A. lumbricoides (1/2) and S.
ansoni (1/2) samples.
Statistically signiﬁcant differences were found considering
edian of RI, comparing antigens captured by G10 and A4 clones,
he last one showed to be more speciﬁc (p = 0.0004). Analyzing
OC curve (Fig. 5), antigens captured by A4 showed to be the most
peciﬁc to discriminate patients with NC from control groups (G2
nd G3). Test performance, indicated by AUC for A4 target (0.998)
lmost reached the maximum value (1.00) of efﬁciency; LR con-
erred to this antigen a very high diagnostic value (60.0).
. Discussion
Phage display antibody technology has become increasing pop-
lar for creating binding sites for use in all areas of research, and
ndustrial applications. There are several examples of successful
solation of antibodies against various antigens from different
hage displayed antibody libraries, including high throughput
election [23–26]. Phage bearing speciﬁc scFv fragments for the
arasite antigen were selected successfully by panning, which
llowed us to obtain, for the ﬁrst time, this kind of recombinant
ntibodies that bind to epitopes on T. solium metacestode. These
ig. 5. ROC curve indicating optimum point of reaction. Sensitivity (Se), speciﬁcity (Sp), a
.  solium metacestodes (A) and the native antigens corresponding to clones G10 (B), A4 (C Letters 156 (2013) 59– 67 65
scFvs likely represent only a fraction of the parasite binding
antibodies and we thus expect the scFv library to remain a useful
resource for further studies of the host-exposed cisticerci epitopes.
Selection of scFv antibodies speciﬁc to phage displayed pep-
tides is not conventional [27] the strategy used here was to select
antibodies speciﬁc to peptides related to neurocysticercosis, NC22
and NC41, previously selected by Ribeiro et al. [12], and also to
the total saline extract of T. solium to identify its targets. It was
demonstrated previously [27] that mimotopes selected from phage
display libraries could be used as targets to obtain scFv highly sen-
sitive and reactive. It is important to emphasize that the option
by direct selection against phage displayed peptides by a subtrac-
tive step using wild type M13  phage was made to avoid peptide
synthesis and loss of the real identity and reactivity of mimotopes,
due to a probable conformation with part of phage pIII. Our results
demonstrate that selections were successful and highly efﬁcient.
Three different, unique scFvs were selected from a scFv library
for their ability to bind to both cisticerci extracts and phage clones
displaying peptides. Dot-blot showed that the recombinant scFvs
reacts with total saline extract of T. solium metacestodes. If these
antibodies can be demonstrated to be T. solium speciﬁc, they can be
good reagents for diagnosis of this parasite in serum samples from
humans and animals. Importantly, it can be easily stored for long
periods and can be cloned for gene encoding.
Immunoﬂuorescence data show functionality of selected clones,
once they were able to bind to its targets. This functionality allowed
us to identify the immunolocation of target antigen at T. solium
metacestode, and different staining proﬁles were achieved. When
B6 clone was  used it was observed tegument staining. In this region
there are cells that actively produce proteins and other compounds
rea under curve (AUC) and likelihood ratio (LR) are show for total saline extract of
) and B6 (D) to detect IgG in serum.
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hat are transported to tegument. There are reports describing pro-
uction of cytoskeleton proteins such as myosin type II and actin
28]. The staining proﬁle reﬂects target identiﬁcations as revealed
y LC–MS/MS where the most abundant protein was actin. Differ-
nt amino acid sequences may  be related to the different reactivity
atterns.
Analyzing potential of captured antigens to detect IgG in serum
amples from NC patients, ROC and TG-ROC curve provided an opti-
al  cut-off point for each antigenic fraction studied. Information
btained from ELISA immunoassay showed a differential IgG detec-
ion proﬁle for each fraction tested. Saline extract (S), and antigens
aptured by B6 and G10 diagnostic parameters were inferior if qual-
tatively compared with those from antigens captured by A4, which
xhibited an increased sensitivity, speciﬁcity, and a higher AUC
alue. According to Jaeschke et al. [29] values of likelihood ratio LR
reater than 10, practically conﬁrm the diagnosis. Therefore, LR’s
howed that antigens captured by A4 had a remarkable diagnos-
ic performance to detect IgG in patients with neurocysticercosis,
eaching values of LR = 60.0.
Comparing our results with those from other authors using
ative, synthetic or recombinant antigens, fractions captured by
cFv clones obtained here showed sensitivity and speciﬁcity val-
es similar or superior to that previously reported [30–35]. Special
ttention should be made to the complete statistical analyses per-
ormed here that revealed very high diagnostic parameters reached
y captured antigens. Our results reinforce the usefulness of mimo-
opes described previously for NC diagnosis [12], and presents the
lternative use of selected scFvs on patients’ follow-up.
Presented data show that was possible to select antibodies
ith appropriate reactivity leading to perspectives on its applica-
ion to capture new antigens with potential diagnostic application.
elected clones can be excellent reagents in the search for promis-
ng vaccine targets, for dissecting the role of antibodies in T. solium
mmunity and for improved understanding of the host/parasite
elationship.
The rationale of using the novel antibodies that target our pre-
iously described recombinant antigens (mimotopes) may be of
reat importance to monitor the evolution of the parasitic infec-
ion and the treatment efﬁcacy. scFv antibodies selected here can
e used for antigen identiﬁcation in cerebrospinal ﬂuid and serum
amples from patients with NC, this usefulness and the economic
dvantage was previously described [36–39], suggesting that anti-
en identiﬁcation may  contribute as to the understanding of the
isease, the characterization of the parasite’s antigenic composi-
ion, besides the use for antigen and antibody detection in humans
nd animals for diagnostic purposes.
In conclusion, antibody fragments speciﬁc to T. solium anti-
ens were successfully selected for the ﬁrst time. The antibody
hage display technology is a useful approach for the study of
ntigen–antibody interactions used to further characterize anti-
ens related to mimotopes with potential use in immunodiagnostic
ests.
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